Square Pharmaceuticals PLC declared Cash Dividend 110 per cent to its Shareholders for the year ended 30 June, 2024 at its 58th Annual General Meeting held under the virtual platform on Wednesday, says a press release.
The AGM was presided over by the Chairman of the Company Samuel S Chowdhury.
Ratna Patra, Vice Chairman; Tapan Chowdhury, Managing Director, Kazi Iqbal Harun, Director, Abul Kalam Azad, Independent Director, Muhammadul Haque, Independent Director, Md Kabir Reza, Head of A&F, Md Zahangir Alam, Chief Financial Officer, and Khandaker Habibuzzaman, Company Secretary attended the meeting.
The Consolidated Net Turnover, Gross Profit, and Net Profit (After Tax) for the year ended 30 June, 2024 were Tk. 70.10 billion, Tk. 33.07 billion and Tk. 18.33 billion respectively. The Consolidated Net Turnover, Gross Profit and Net Profit rose to 15.47%, 13.87% and 11.53% respectively during the year under review.
